Challenges in the management of chronic pulmonary aspergillosis

Med Mycol. 2017 Jan 1;55(1):63-68. doi: 10.1093/mmy/myw119. Epub 2016 Dec 2.

Abstract

The management of chronic pulmonary aspergillosis (CPA) presents multiple challenges. We present three cases that illustrate some of the most challenging aspects of caring for patients with CPA: specifically, antifungal drug resistance, drug interactions, coinfection with nontuberculous mycobacteria, and large-volume hemoptysis.

Keywords: case series; chronic pulmonary aspergillosis; haemoptysis; non-tuberculous mycobacteria; resistance.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Chronic Disease
  • Disease Management*
  • Drug Interactions
  • Drug Resistance, Fungal
  • Humans
  • Mycobacterium Infections / complications
  • Pulmonary Aspergillosis / complications
  • Pulmonary Aspergillosis / diagnosis*
  • Pulmonary Aspergillosis / drug therapy*

Substances

  • Antifungal Agents